Stay updated on Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page
- ChecktodayChange DetectedThe page shows an update to the site’s software/UI revision from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check36 days agoChange DetectedThe page footer now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check50 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision label on the page updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedThe update is a minor metadata revision (Revision: v3.4.1 added; Revision: v3.4.0 removed) with no changes to study data or page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check101 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.